U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086937) titled 'Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children' on July 17.
Brief Summary: This study aimed at comparing the efficacy of nitazoxanide-based triple therapy versus standard triple therapy for eradication of Helicobacter pylori infection in children at a tertiary care hospital.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Helicobacter Pylori Infection
Intervention:
DRUG: Nitazoxanide
Children were given nitazoxanide, PPI, and clarithromycin for 14 days.
DRUG: Metronidazole
Children received MTZ, PPI, and clarithromycin for 14 days.
DRUG: PPI
Children were given om...